These cells can be identified based on the presence of surface biomarkers such as CD44/CD24 and aldehyde dehydrogenase1 (ALDH1), in-vitro formation of spheroid or colonies, and in-vivo augmentation of tumor-initiating potential as well as tumorigenic ability [1, 57]. This evidence concerns the gene CD24 and neoplasm.